Mannkind (MNKD) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 15.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | -135.14% |
| Sep 30, 2025 | 153.35% |
| Jun 30, 2025 | 133.50% |
| Mar 31, 2025 | -195.14% |
| Dec 31, 2024 | 4.46% |
| Sep 30, 2024 | 7.70% |
| Jun 30, 2024 | 47.65% |
| Mar 31, 2024 | 479.84% |
| Dec 31, 2023 | 1,012.37% |
| Sep 30, 2023 | 130.86% |
| Jun 30, 2023 | 108.12% |
| Mar 31, 2023 | 106.33% |
| Dec 31, 2022 | 80.76% |
| Sep 30, 2022 | -84.89% |
| Jun 30, 2022 | -49.12% |
| Mar 31, 2022 | -43.34% |
| Dec 31, 2021 | -5,354.04% |
| Sep 30, 2021 | -12.81% |
| Jun 30, 2021 | -482.17% |
| Mar 31, 2021 | -13.48% |
| Dec 31, 2020 | 104.60% |
| Sep 30, 2020 | 74.14% |
| Jun 30, 2020 | 81.33% |
| Mar 31, 2020 | 3.26% |
| Dec 31, 2019 | -120.44% |
| Sep 30, 2019 | -273.96% |
| Jun 30, 2019 | 27.34% |
| Mar 31, 2019 | 46.43% |
| Dec 31, 2018 | 183.35% |
| Sep 30, 2018 | 40.18% |
| Jun 30, 2018 | -35.52% |
| Mar 31, 2018 | -354.50% |
| Dec 31, 2017 | -135.11% |
| Sep 30, 2017 | -0.86% |
| Jun 30, 2017 | -74.07% |
| Mar 31, 2017 | 127.66% |
| Dec 31, 2016 | 43.45% |
| Sep 30, 2016 | -15.98% |
| Jun 30, 2016 | 35.38% |
| Mar 31, 2016 | -1,118.48% |
| Dec 31, 2015 | 36.91% |
| Sep 30, 2015 | -119.84% |
| Jun 30, 2015 | 23.95% |
| Mar 31, 2015 | 108.16% |
| Dec 31, 2014 | -4.97% |
| Sep 30, 2014 | 404.58% |
| Jun 30, 2014 | 21.27% |
| Mar 31, 2014 | -15.50% |
| Dec 31, 2013 | -21.19% |
| Sep 30, 2013 | 3.93% |
| Jun 30, 2013 | -18.89% |
| Mar 31, 2013 | 1.41% |
| Dec 31, 2012 | -38.04% |
| Sep 30, 2012 | 4.93% |
| Jun 30, 2012 | 31.91% |
| Mar 31, 2012 | -5.80% |
| Dec 31, 2011 | 47.77% |
| Sep 30, 2011 | -3.41% |